Airain ltd increased its position in CVS Health Corporation (NYSE:CVS) by 1,455.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 183,156 shares of the pharmacy operator’s stock after buying an additional 171,381 shares during the period. Airain ltd’s holdings in CVS Health Corporation were worth $14,378,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Pioneer Investment Management Inc. boosted its position in shares of CVS Health Corporation by 4.6% in the first quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock valued at $630,598,000 after buying an additional 353,621 shares during the period. Parnassus Investments CA boosted its position in shares of CVS Health Corporation by 2.9% in the first quarter. Parnassus Investments CA now owns 6,237,016 shares of the pharmacy operator’s stock valued at $473,605,000 after buying an additional 175,695 shares during the period. LSV Asset Management boosted its position in shares of CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after buying an additional 1,404,384 shares during the period. APG Asset Management N.V. boosted its position in shares of CVS Health Corporation by 2.2% in the first quarter. APG Asset Management N.V. now owns 3,841,827 shares of the pharmacy operator’s stock valued at $301,583,000 after buying an additional 81,193 shares during the period. Finally, Swiss National Bank boosted its position in shares of CVS Health Corporation by 26.9% in the first quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after buying an additional 811,100 shares during the period. 81.53% of the stock is owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.6588% during midday trading on Monday, hitting $75.8464. 1,026,632 shares of the company were exchanged. CVS Health Corporation has a one year low of $69.30 and a one year high of $94.30. The company’s 50 day moving average price is $78.28 and its 200 day moving average price is $78.95. The firm has a market cap of $77.10 billion, a P/E ratio of 15.1088 and a beta of 0.91.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 EPS. Equities analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.65%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s payout ratio is presently 39.92%.

TRADEMARK VIOLATION NOTICE: “CVS Health Corporation (CVS) Stake Boosted by Airain ltd” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/cvs-health-corporation-cvs-stake-boosted-by-airain-ltd/1528131.html.

CVS has been the topic of several research analyst reports. Evercore ISI restated an “outperform” rating and set a $88.00 price objective (up from $87.00) on shares of CVS Health Corporation in a research note on Wednesday, May 3rd. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $85.96 price objective on the stock in a research note on Wednesday, May 17th. ValuEngine cut CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday. Finally, Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $90.83.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of CVS Health Corporation stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the transaction, the executive vice president now directly owns 59,300 shares of the company’s stock, valued at approximately $4,564,914. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard J. Swift sold 2,500 shares of CVS Health Corporation stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the transaction, the director now directly owns 3,258 shares in the company, valued at $259,401.96. The disclosure for this sale can be found here. Insiders have sold a total of 273,675 shares of company stock worth $21,831,647 over the last ninety days. Company insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.